1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma
(
- Contribution to journal › Article
- 2007
-
Mark
Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin
(
- Contribution to journal › Article
-
Mark
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
(
- Contribution to journal › Article
- 2006
-
Mark
Tissue transglutaminase autoantibodies in childhood celiac disease
(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without Helicobacter pylori infection
(
- Contribution to journal › Article
- 2004
-
Mark
Red blood cells as modulators to T cell growth and survival
(
- Contribution to journal › Scientific review